Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Malaria Falciparum
74%
Malaria
63%
Antimalarial Agent
50%
Artesunate
43%
Acquired Immune Deficiency Syndrome
38%
Artemether Plus Benflumetol
26%
Artemisinin
26%
Drug Resistance
25%
Cohort Study
25%
Mefloquine
23%
Tenofovir
21%
Combination Therapy
20%
Pharmacokinetic
19%
Infection
18%
Keyphrases
COVID-19
60%
HIV-infected Patients
57%
Falciparum Malaria
46%
Malaria
43%
Combined Antiretroviral Therapy (cART)
42%
95% Confidence Interval
40%
Antiretroviral Therapy
32%
Travellers
31%
CD4 Cell Count
31%
AIDS/HIV
29%
Donor-acceptor
26%
Artesunate
25%
Artemether-lumefantrine
23%
Malaria Control
23%
D Study
22%
Medicine and Dentistry
Human immunodeficiency virus
86%
Malaria
64%
Infection
34%
Antiretroviral Therapy
33%
Acquired Immune Deficiency Syndrome
25%
Hepatitis B
22%
COVID-19
21%
Malaria Falciparum
21%
Health Care Personnel
20%
Malaria Control
20%
Hepatitis B Virus
19%
Tenofovir
15%
Randomized Controlled Trial
15%
Antimalarial Drug Resistance
15%
Cross Sectional Study
14%